Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1743-1748

  Nakashima, Jun ^a   Tachibana, Masaaki ^a   Ueno, Munehisa ^a   Miyajima, Akira ^a   Baba, Shiro ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD LEVEL; BODY MASS; CACHEXIA; CANCER RECURRENCE; CANCER REGRESSION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0031746794     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. O'Keefe, S. J. D., Ogden, J., Ramjee, G., and Rund, J. Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma. Cancer Res., 50: 1226-1230, 1990.
2. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, S. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 25: 3666-3670, 1975.
3. Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., and Cerami, A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp. Med., 161: 984-995, 1985.
4. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C., Mathison, J., Ulevitch, R., and Cerami, A. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature (Lond.), 316: 552-554, 1985.
5. Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., Cerami, A., and Lowry, S. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med., 167: 1211-1227, 1988.
6. Blick, M., Sherwin, S. A., Rosemblum, M., and Gutterman, J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res., 47: 2986-2989, 1987.
7. Brenner, D. A., Buck, M., Feitelberg, S. P., and Chojkier, M. Tumor necrosis factor-α inhibits albumin gene expression in a murine model of cachexia. J. Clin. Invest., 85: 248-255, 1990.
8. Tessitore, L., Costelli, P., and Baccino, F. M. Humoral mediation for cachexia in tumor-bearing rats. Br. J. Cancer, 67: 15-23, 1993.
9. Feingold, K. R., Soued, M., Serio, M. K., Moser, A. H., Dinarello, C. A., and Grunfeld, C. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology, 125: 267-274, 1989.
10. Feingold, K. R., and Grunfeld, C. Tumor necrosis factor-α stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Invest, 80: 184-190, 1987.
11. Grunfeld, C., Wilking, H., Neese, R., Larry, A. G., Moser, A. H., Gulli, R., Serio, M. K., and Feingold, K. R. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res., 49: 2554-2560, 1989.
12. Lahdevirta, J., Maury, C. P. J., Teppo, A-M., and Repo, H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with AIDS. Am. J. Med., 85: 289-291, 1988.
13. Levine, B., Kalman, J., Mayer, L., Fillit, H. M., and Packer, M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med., 323: 236-241, 1990.
14. McMurray, J., Abdullah, I., Dargie, H. J., and Shapiro, D. Increased concentrations of tumor necrosis factor in "cachectic" patients with severe chronic heart failure. Br. Heart J., 66: 356-358, 1991.
15. Oliff, A., Defeo-Jones, D., Boyer, M., Martinez, D., Kiefer, D., Vuocolo, G., Wolfe, A., and Socher, S. H. Tumor secreting human TNF/cachectin induce cachexia in mice. Cell, 50: 555-563, 1987.
16. Fandrey, J., and Jelkmann, W. E. B. Interleukin-1 and tumor necrosis factor-α inhibit erythropoietin production in vitro. Ann. NY Acad. Sci., 628: 250-255, 1991.
17. Peetre, C., Gullberg, U., Nilsson, E., and Olsson, I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. J. Clin. Invest., 78: 1694-1700, 1986.
18. Mallmann, P., Diedrich, K., Mallmann, R., Koenig, U. D., and Krebs, D. Determination of TNF α, IFN α, interleukin 2 and reactivity in the leukocyte migration inhibition test in breast cancer patients. Anticancer Res., 11: 1509-1516, 1991.
19. Girardin, E., Gerorges, E. G., Dayer, J-M., Roux-Lombard, P., The J5 Study Group, and Lambert, P-H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med., 319: 397-400, 1988.
20. Waage, A., Halstensen, A., and Espevik, T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet, 1: 355-357, 1987.
21. Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., Vassalli, P., Hommel, M., and Lambert, P-H. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med., 320: 1586-1591, 1989.
22. Mooradian, A. D., Reed, R. L., Osterweil, D., and Scuderi, P. Detectable serum levels of tumor necrosis factor α may predict early mortality in elderly institutionalized patients. J. Am. Geriatr. Soc., 39: 891-894, 1991.
23. Stovroff, M. C., Fraker, D. L., Travis, W. D., and Norton, J. A. Altered macrophage activity and tumor necrosis factor: tumor necrosis and host cachexia. J. Surg. Res., 46: 462-469, 1989.
24. Yoneda, T., Alsina, M. A., Chavez, J. B., Bonewald, L., Nishimura, R., and Mundy, G. R. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J. Clin. Invest., 87: 977-985, 1991.
25. Tracey, K. J., Morgello, S., Kolpin, V., Fahey, T. J., Dox, J., Aledo, A., Manogue, K. R., and Cerami, A. Metabolic effects of cachectin/ tumor necrosis factor are modified by site of production: cachectin/ tumor necrosis factor secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J. Clin. Invest., 86: 2014-2024, 1990.
26. Beutler, B., Milsark, I. W., and Cerami, A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (Washington DC), 229: 869-871, 1985.
27. Grau, G. E., Fajardo, L. F., Piguet, P-F., Allet, B., Lambert, P-H., and Vassalli, P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (Washington DC), 237: 1210-1212, 1987.
28. Sherry, B. A., Gelin, J., Fong, Y., Maran, M., Wei, H., Cerami, A., Lowry, S. F., Lundholm, K. G., and Moldawer, L. L. Anticachectin/ tumor necrosis factor-α antibodies attenuate development of cachexia in tumor models. FASEB J., 3: 1956-1962, 1989.
29. Teng, M. N., Park, B. H., Koeppen, H. K. W., Tracey, K. J., Fendly, B. M., and Schreiber, H. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. USA, 88: 3535-3539, 1991.
30. Teng, M. N., Turksen, K., Jacobs, C. A., Fuchs, E., and Schreiber, H. Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein. Clin. Immunol. Immunopathol., 69: 215-222, 1993.
31. Langstein, H. N., and Norton, J. A. Mechanisms of cancer cachexia. Hematol. Oncol. Clin. N. Am., 5: 103-123, 1991.
32. Balkwill, F., Osborne, R., Burke, F., Naylor S., Talbot, D., Durbin, H., Tavernier, J., and Friers W. Evidence for tumor necrosis factor/ cachectin production in cancer. Lancet, ii: 1229-1232, 1987.
33. Knapp, M. L., Al-Sheibani, S., Riches, P. G., Hanham, I. W. F., and Phillips, R. H. Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann. Clin. Biochem., 28: 480-486, 1991.